Drugs / [123I]β-CIT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00315250 | Jan 2006 → Jan 2010 | Parkinson disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [123I]β-CIT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00315250 ↗ |